Top brand choice
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
ELIQUIS (apixaban) is a medication indicated for the following conditions:
Atrial fibrillation is an irregular heart rhythm where the left atrium of the heart “quivers,” rather than pumps blood adequately into the left ventricle of the heart. The irregular “quivering” slows the flow of blood, increasing the risk of clot formation (embolism) within the left atrium.
ELIQUIS medication works by binding to and inhibiting factor Xa (ten A), a critical protein in the natural clotting cascade. Inhibiting factor Xa reduces the formation of clots and decreases the risk of embolism.
ELIQUIS medication is usually prescribed at 5 mg taken twice daily.
The recommended dosage is 2.5 mg twice daily in patients with two or more of the following characteristics: age ≥ 80 years, body weight ≤ 60 kg, or serum creatinine ≥ 1.5 mg/dL.
The active ingredient in ELIQUIS is apixaban.
The following forms are available:
ELIQUIS medication is contraindicated in patients when active bleed or a hypersensitivity (allergy) to any of the ingredients in the medication.
ELIQUIS medication was not studied in patients with prosthetic heart valves, and usage is not recommended in these patients.
The most common side effects of ELIQUIS medication are an increased risk of bleeding. Speak with your doctors about your risk of bleeding and how to recognize the signs and symptoms of bleeding problems.
The bleeding side effects of ELIQUIS medication are increased when combined with certain medications like anticoagulants, antiplatelet agents, heparin, selective serotonin reuptake inhibitors (SSRIs), thrombolytic agents, and non-steroidal anti-inflammatory drugs (NSAIDs). If you are taking any of these medications concurrently with ELIQUIS medication, speak with your doctor.